Indicator summary: Leaning bearish (1 bullish, 3 bearish, 1 neutral). As of 2026-11-05, the close was $62.15: 3.1% below the 50-day average and 2.7% below the 200-day average, which is rising. RSI (14) is 37, in its neutral range. MACD is bearish after a cross in the last 10 days. The stock sits 65% of the way up its 52-week range of $55.10 to $66.01, on 0.5x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $64.16 | Price 3.1% below |
| 200-day average | $63.84 | Price 2.7% below, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 37 | Neutral range |
| MACD (12, 26, 9) | -0.29 vs -0.14 | Bearish cross in the last 10 days |
| 52-week range | $55.10 to $66.01 | 65% of the way up the range |
| Volume vs 20-day average | 0.5x | Light |
Base rates use CCZ's own daily history since 1999; they describe the past, not a forecast.
As of 2026-11-05, CCZ's 14-day RSI is 37, which is in the neutral range between 30 and 70.
No. CCZ closed at $62.15 on 2026-11-05, 2.7% below its 200-day average of $63.84, which is rising. When it closed below its 200-day average (2,156 days), it was higher 63 trading days later 68% of the time, median +3.7%.
No. CCZ closed at $62.15 on 2026-11-05, 3.1% below its 50-day average of $64.16. When it closed below its 50-day average (2,784 days), it was higher 63 trading days later 66% of the time, median +3.4%.
Yes, a bearish cross within the last 10 trading days. As of 2026-11-05 the MACD line is -0.29 against a signal line of -0.14, so MACD is bearish.
No. At $62.15 it sits 65% of the way up its 52-week range of $55.10 to $66.01, 5.8% below the high.
Leaning bearish: 1 of 5 indicators are bullish and 3 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: SS-Buy, from the chart signal model.
CCZ analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.